ACTA2: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Vascular diseases]] | [[Category:Vascular diseases]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:56, 17 March 2025
ACTA2[edit]
ACTA2 (Actin, Alpha 2, Smooth Muscle, Aorta) is a gene that encodes a protein known as smooth muscle alpha-actin, which is a major component of the contractile apparatus in smooth muscle cells. This protein is crucial for the function of smooth muscle tissues, which are found in various parts of the body, including blood vessels, the gastrointestinal tract, and the respiratory system.
Function[edit]
The ACTA2 gene provides instructions for making the smooth muscle alpha-actin protein. This protein is part of the actin family, which are highly conserved proteins that play a role in cell motility, structure, and integrity. In smooth muscle cells, alpha-actin is a key component of the contractile apparatus, which is responsible for muscle contraction and relaxation. This process is essential for maintaining blood pressure and flow, as well as for the movement of food through the digestive tract.
Clinical Significance[edit]
Mutations in the ACTA2 gene have been associated with a variety of vascular diseases. These include:
- **Familial Thoracic Aortic Aneurysm and Dissection (TAAD):** Mutations in ACTA2 can lead to the weakening of the aortic wall, resulting in aneurysms and dissections.
- **Multisystemic Smooth Muscle Dysfunction Syndrome:** This rare condition is characterized by dysfunction in multiple smooth muscle-containing organs, leading to symptoms such as patent ductus arteriosus, bladder dysfunction, and gastrointestinal issues.
Research and Studies[edit]
Research on ACTA2 has focused on understanding its role in vascular diseases and developing potential therapeutic interventions. Studies have shown that ACTA2 mutations can disrupt the normal function of smooth muscle cells, leading to increased risk of vascular complications.
Genetic Testing[edit]
Genetic testing for ACTA2 mutations can be used to identify individuals at risk for related vascular conditions. This can be particularly useful for family members of affected individuals, allowing for early intervention and management.
Also see[edit]
| Genetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
| Cardiovascular disease (vessels) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|